Timber Pharmaceuticals Inc (NYSE American:TMBR)
| 1.40 Delayed Data As of Nov 25 |  -0.06 / -4.11%Today’s Change | 1.37 Today|||52-Week Range 24.95 | -92.63% Year-to-Date |
Latest TMBR News | Press Releases
No recent news for Timber Pharmaceuticals Inc.
Today’s Trading
| Previous close | 1.46 |
| Today’s open | 1.42 |
| Day’s range | 1.40 - 1.49 |
| Volume | 66,010 |
| Average volume (3 months) | 258,479 |
| Market cap | $4.2M |
Data as of 1:18pm ET, 11/25/2022
Growth & Valuation
| Earnings growth (last year) | +66.43% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -100.00% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NVIVInVivo Therapeutics ... | -0.16 | -6.87% |
| ---- | ||
| FWBIFirst Wave BioPharma... | +0.02 | +3.00% |
| CWBRCohBar Inc | -0.02 | -1.27% |
Data as of 12:59pm ET, 11/25/2022
Financials
| Next reporting date | March 21, 2023 |
| EPS forecast (this quarter) | -$1.50 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$9.7M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Basking Ridge, New Jersey |
Forecasts
